fda news tirzepatide The @U.S. Food and Drug Administration (@fda ) has accepted @Sandoz 's applications for review of two generic versions of tirzepatide, the active ingredient in Eli Lilly and Company 's blockbuster drugs FDA says the tirzepatide weight-loss

Our Mounjaro (Tirzepatide) Program combines medical science with compassionate care to help patients with type 2 diabetes , obesity , or difficulty losing weight achieve real, lasting results

Semaglutide isnt suitable for everyone

The researchers suggest that GLP-1 medications may provide a double benefit: potentially slowed cancer growth reduced risk of heart attack and stroke, which also improves survival The results were published in Cancer Investigation and are in line with other research on GLP-1 and cancer

Combining these with bupropion XL increases this risk even more

If you use Wegovy and an antibiotic, tell your doctor right away if you have symptoms of low blood sugar